Dr. Leen Wehbeh, MD

Dr. Wehbeh practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Wehbeh's NPI, 1801215892, was assigned on April 7, 2014. Dr. Wehbeh holds Maryland license D0089517.

Dr. Wehbeh's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Wehbeh's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Wehbeh is also affiliated with The Johns Hopkins Hospital. The medical group on file is UM St. Joseph Medical Group. Dmand AI also links Dr. Wehbeh to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wehbeh practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Wehbeh's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Wehbeh is licensed in Maryland.

CMS data shows 1,248 Medicare services from Dr. Wehbeh across 6 procedure codes in 2024, for 585 Medicare patients. Medicare paid $71,807 for them.

CMS counts 585 Medicare patients who saw Dr. Wehbeh in 2024. The largest group is 65 to 74, with 295 patients. 75% of them have high cholesterol, and 75% have osteoporosis. 8% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wehbeh's median patient age at 71, with 75% women.

In 2024, Dr. Wehbeh wrote 1,241 Medicare Part D claims for 293 patients. 54% of them were for generic drugs. CMS names the drug for 1,040 of them, across 25 drugs with 11 or more claims each, at $2,111,683 in total drug cost. In 2023, CMS named 526 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Wehbeh for performance year 2024, reported as part of a group. Dr. Wehbeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wehbeh as offering telehealth.

Dmand AI links 8 papers to Dr. Wehbeh, published from 2019 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Analgesics, Opioid and Hypogonadism. Dr. Wehbeh has published most often in J Clin Endocrinol Metab. Dr. Wehbeh's most frequent co-authors are Todd T. Brown, MD, Kenneth Dale Burman, MD and Sunita Sunita Dia, MD.

CMS Open Payments shows 24 general payments to Dr. Wehbeh from 14 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 92% of the total. Beta Bionics, Inc. paid the most, $299.